References
- Singh P, Kumar A, Das S, et al. Management of superficial bladder carcinoma: time to rethink the treatment strategies in the era of orthotopic neo-bladder. Saudi J Kidney Dis Transplant. [Internet]. 2010;21(5):881–885. Available from: https://www.sjkdt.org/article.asp?issn=1319-2442
- Lenis AT, Lec PM, Chamie K, et al. Bladder cancer: a review. JAMA. [Internet]. 2020; 324(19):1980–1991. Available from: https://doi.org/10.1001/jama.2020.17598
- Alhunaidi O, Zlotta AR. The use of intravesical BCG in urothelial carcinoma of the bladder. Ecancermedicalscience. [Internet]. 2019; 13:905 Available from: https://pubmed.ncbi.nlm.nih.gov/30915163
- Crabb SJ, Douglas J. The latest treatment options for bladder cancer. Br Med Bull. [Internet]. 2018; 128(1):85–95. Available from: https://doi.org/10.1093/bmb/ldy034
- Guo Y, Liu Z, Li K, et al. Paris polyphylla-derived saponins inhibit growth of bladder cancer cells by inducing mutant P53 degradation while up-regulating CDKN1A expression. Curr Urol. [Internet]. 2018;11(3):131–138. Available from: https://doi.org/10.1159/000447207
- Tanaka MF, Sonpavde G. Diagnosis and management of urothelial carcinoma of the bladder. Postgrad Med. [Internet]. 2011;123(3):43–55. Available from: https://doi.org/10.3810/pgm.2011.05.2283
- Larocca CA, LeBoeuf NR. Overview of cutaneous T-Cell lymphomas. Hematol Oncol Clin North Am. [Internet]. 2019; 133(4):669–686. Available from: https://doi.org/10.1016/j.hoc.2019.04.004
- Peng M, Xiao D, Bu Y, et al. Novel combination therapies for the treatment of bladder cancer. Front Oncol. [Internet]. 2020;10:539527Available from: https://doi.org/10.3389/fonc.2020.539527
- Pulitzer M. Cutaneous T-cell Lymphoma. Clin Lab Med. [Internet]. 2017;37(3):527–546. Available from: https://doi.org/10.1016/j.cll.2017.06.006
- Oka T, Miyagaki T. Novel and future therapeutic drugs for advanced mycosis fungoides and sézary syndrome. Front Med (Lausanne)). [Internet]. 2019;6:116. Available from: https://doi.org/10.3389/fmed.2019.00116
- Geskin L, Malone DC. An exploratory cost-effectiveness analysis of systemic treatments for cutaneous T-cell lymphoma. J Dermatolog Treat. [Internet]. 2018;29(5):522–530. Available from: https://doi.org/10.1080/09546634.2017.1412064
- Guenova E, Hoetzenecker W, Rozati S, et al. Novel therapies for cutaneous T-cell lymphoma: what does the future hold? Expert Opin Investig Drugs. [Internet]. 2014;23(4):457–467. Available from: https://doi.org/10.1517/13543784.2014.876407
- Brouwer IJ, Out-Luiting JJ, Vermeer MH, et al. Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in sézary cells. Biochem Biophys Reports [Internet]. 2020;24:100832. Available from: https://www.sciencedirect.com/science/article/pii/S2405580820301424
- PDQ Adult Treatment Editorial Board. Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®): Health Professional Version. PDQ Cancer Inf Summ [Internet]. 2002; Available from: http://www.ncbi.nlm.nih.gov/pubmed/26389288.
- Kaufman DS. Challenges in the treatment of bladder cancer. Ann Oncol. [Internet]. 2006;17(5):v106–12. Available from: https://www.sciencedirect.com/science/article/pii/S0923753419382006
- Sasaki M, Hashimoto H, Yachiku S. Studies on enhancement of drug absorption through the bladder mucosa. Nihon Hinyokika Gakkai Zasshi. [Internet]. 1994;85(9):1353–1362. Available from: https://doi.org/10.5980/jpnjurol1989.85.1353
- Giannantoni A, Di Stasi SM, Chancellor MB, et al. New frontiers in intravesical therapies and drug delivery. Eur Urol. [Internet]. 2006;50(6):1183–1193. Available from: https://www.sciencedirect.com/science/article/pii/S0302283806009687
- Zhang C, Li B, Gaikwad AS, et al. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. J Invest Dermatol. [Internet]. 2008;128(11):2728–2735. Available from: https://www.sciencedirect.com/science/article/pii/S0022202X15336708
- Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. [Internet]. 2018;32(19-20):1267–1284. Available from: http://genesdev.cshlp.org/content/32/19-20/1267.abstract
- Ionkova I, Shkondrov A, Krasteva I, et al. Recent progress in phytochemistry, pharmacology and biotechnology of astragalus saponins. Phytochem Rev. 2014;13(2):343–374.
- Elenga PA, Nikolov S, Panova D. Triterpene glycosides and sterols from Astragalus glycyphyllos L. Pharmazie. 1986;41(4):41–42.
- Elenga PA, Nikolov S, Panova D. Triterpene glycosides from Astragalus glycyphyllos L. a new natural compound of the overgrowing parts of Astragalus glycyphyllos L. Pharmazie. 1987;42(6):422–423.
- Linnek J, Mitaine-Offer AC, Miyamoto T, et al. Two cycloartane-type glycosides from the roots of Astragalus glycyphyllos. Planta Med. 2008;74(09):PB141.
- Shkondrov A, Krasteva I, Bucar F, et al. A new tetracyclic saponin from Astragalus glycyphyllos L. and its neuroprotective and hMAO-B inhibiting activity. Nat Prod Res. [Internet]. 2020; Feb 1634(4):511–517. Available from: https://doi.org/10.1080/14786419.2018.1491040
- Shkondrov A, Simeonova R, Kondeva-Burdina M, et al. Study to evaluate the antioxidant activity of Astragalus glycyphyllos extract in carbon tetrachloride-induced oxidative stress in rats. EJMP. [Internet]. 2015;7(2):59–66. Available from: http://www.sciencedomain.org/abstract.php?iid=1018&id=13&aid=8249
- Georgieva A, Popov G, Shkondrov A, et al. Antiproliferative and antitumour activity of saponins from Astragalus glycyphyllos on myeloid Graffi tumour. J Ethnopharmacol. 2021;267:113519.
- Shkondrov A, Krasteva I, Ionkova I, et al. Production of saponins from in vitro cultures of Astragalus glycyphyllos and their antineoplastic activity. Biotechnol Biotechnol Equip [Internet]. 2019;33(1):1413–1418. Available from: https://doi.org/10.1080/13102818.2019.1671222
- Aluani D, Tzankova V, Kondeva-Burdina M, et al. Еvaluation of biocompatibility and antioxidant efficiency of chitosan-alginate nanoparticles loaded with quercetin. Int J Biol Macromol. [Internet]. 2017;103:771–782. Available from: https://www.sciencedirect.com/science/article/pii/S0141813017304798
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.
- Krasteva I, Momekov G, Zdraveva P, et al. Antiproliferative effects of a flavonoid and saponins from Astragalus hamosus against human tumor cell lines. Pharmacogn Mag. 2008;4(16):269–272.
- Dineva I, Krasteva I, Berger M, et al. In vitro antineoplastic activity of some cytoreductive drugs versus new compounds of plant origin. Int J Curr Chem. 2010;1(4):281–290.
- Krasteva IN, Toshkova RA, Nikolov SD. Protective effect of Astragalus corniculatus saponins against myeloid graffi tumour in hamsters. Phytother Res. [Internet]. 2004;18(3):255–257. Available from: https://doi.org/10.1002/ptr.1277
- Toshkova RA, Krasteva IN, Wesselinova DW, et al. Influence of purified saponin mixture from Astragalus corniculatus bieb: on phagocytic cells in graffi-tumor bearing hamsters. J Ethnopharmacol. 2007;109(3):394–399.
- Toshkova RA, Krasteva IN, Nikolov SD. Immunorestoration and augmentation of mitogen lymphocyte response in graffi tumor bearing hamsters by purified saponin mixture from astragalus corniculatus. Phytomedicine. 2008;15(10):876–881.
- Verotta L, Guerrini M, El-Sebakhy NA, et al. Cycloartane and oleanane saponins from egyptian astragalus spp. as modulators of lymphocyte proliferation. Planta Med. 2002; Nov68(11):986–994.
- Nalbantsoy A, Nesil T, Erden S, et al. Adjuvant effects of Astragalus saponins macrophyllosaponin B and astragaloside VII. J Ethnopharmacol. [Internet]. 2011;134(3):897–903. Available from: https://www.sciencedirect.com/science/article/pii/S0378874111000699
- Yesilada E, Bedir E, Çalış İ, et al. Effects of triterpene saponins from astragalus species on in vitro cytokine release. J Ethnopharmacol. [Internet]. 2005;96(1-2):71–77. Available from: https://www.sciencedirect.com/science/article/pii/S0378874104004568
- Zhang J, Wu C, Gao L, et al. Chapter Four – Astragaloside IV derived from Astragalus membranaceus: a research review on the pharmacological effects. In: Du G, editor. Pharmacological Advances in Natural Product Drug Discovery [Internet]. Academic Press; 2020. p. 89–112. (Vol. 87; Advances in pharmacology). Available from: https://www.sciencedirect.com/science/article/pii/S105435891930064X.
- Cai T, Zhang C, Zhao Z, et al. The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats. Biomed Pharmacother. [Internet]. 2018;104:291–299. Available from: https://www.sciencedirect.com/science/article/pii/S0753332218304943
- Huang L, Yao Y, Li J, et al. The effect of astragaloside IV on immune function of regulatory T cell mediated by high mobility group box 1 protein in vitro. Fitoterapia. [Internet]. 2012;83(8):1514–1522. Available from: https://www.sciencedirect.com/science/article/pii/S0367326X12002420
- Jin H, Wang L, Li B, et al. Astragaloside IV ameliorates airway inflammation in an established murine model of asthma by inhibiting the mtorc1 signaling pathway. Clement Y, editor. Evidence-Based Complement Altern Med [Internet]. 2017. 2017:4037086. Available from: https://doi.org/10.1155/2017/4037086
- Li J, Huang L, Wang S, et al. Astragaloside IV attenuates inflammatory reaction via activating immune function of regulatory T-cells inhibited by HMGB1 in mice. Pharm Biol. [Internet]. 2016;54(12):3217–3225. Available from: https://doi.org/10.1080/13880209.2016.1216133
- Vieyra-Garcia P, Crouch JD, O’Malley JT, et al. Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma. JCI Insight. [Internet]. 2019;4(1). Available from: https://doi.org/10.1172/jci.insight.124233
- Nasu K, Said J, Vonderheid E, et al. Immunopathology of cutaneous T-cell lymphomas. Am J Pathol. [Internet]. 1985;119(3):436–447. Available from: https://pubmed.ncbi.nlm.nih.gov/3893149
- Krejsgaard T, Odum N, Geisler C, et al. Regulatory T cells and immunodeficiency in mycosis fungoides and sézary syndrome. Leukemia [Internet]. 2012;26(3):424–432. Available from: https://doi.org/10.1038/leu.2011.237
- Guan Z, Chen L, Zhou Y, et al. The synergistic antitumour effect of multi-components from pulsatilla chinensis saponins in NCI-H460 lung cancer cell line through induction of apoptosis. Pharm Biol. ]. 2020;58(1):427–437. Available from: https://doi.org/10.1080/13880209.2020.1761404
- Herrmann F, Wink M. Synergistic interactions of saponins and monoterpenes in HeLa cells, Cos7 cells and in erythrocytes. Phytomedicine. ]. 2011;18(13):1191–1196. Available from: https://www.sciencedirect.com/science/article/pii/S0944711311003564